Log out

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201.

O's Europe Qlty Divd ETF (OEUR)

$23.55 0.09 (0.38%)

19:59 EDT OEUR Stock Quote Delayed 30 Minutes

Volume:

Previous Close $23.55

Market Cap 188,400

PE Ratio -

EPS -

Volume (Avg. Vol.) 8,800

Day's Range 23.40 - 23.55

52-Week Range 16.35 - 26.02

Dividend & Yield 0.77 (3.26%)

OEUR Stock Predictions, Articles, and O's Europe Qlty Divd ETF News

From the Web

Lilly's sintilimab shows treatment benefit in first-line lung cancer (NYSE:LLY)

From Seeking Alpha Aug 8, 2020

Following up on their initial announcement in January, Eli Lilly (NYSE:LLY) and China development partner Innovent Biologics (OTCPK:IVBIY) announce detailed results from a China-based Phase 3 clinical trial, ORIENT-11, evaluating the combination of PD-1 inhibitor Tyvyt (sintilimab), Alimta (pemetrexed) and platinum chemo for the first-line treatment of patients with nonsquamous non-small cell lung cancer (NSCLC) without sensitive EGFR mutation or ALK rearrangement.The data were presented virtually at the World Conference on Lung Cancer Presidential Symposium.The addition of Tyvyt to Alimta and chemo resulted in a statistically significant improvement in progression-free survival (PFS) compared to placebo + Alimta + chemo.

Biosimilars Market : Growth Drivers and Future Opportunities : Impact of Covid 19 Detailed Analysis

From SBWire Aug 7, 2020

The Global Biosimilars Market is poised to reach $35.7 billion by 2025. Biosimilars Products Market Report provides crucial industry insights that will help your business grow

Pharmaceutical Drugs for Therapy Market SWOT Analysis by Key Players: Bayer, GSK, Adcock Ingram

From SBWire Aug 5, 2020

The Pharmaceutical Drugs for Therapy Market research study presents insights into the changing competitive landscape and offers clients an accurate picture of the future direction of this industry. (To Know More & Enquire for customization in Report….CLICK HERE)

Pharma ETFs Soar on Robust Q2 Earnings

From Zacks Investment Research Aug 7, 2020

Total earnings of 66.4% of the healthcare market capitalization that has reported so far are up 4.4% on revenue growth of 4%.

Pharma Stock Roundup: ABBV, MRK Q2 Earnings & Coronavirus Updates in Focus

From Zacks Investment Research Aug 7, 2020

Sanofi (SNY)/Glaxo (GSK) and J&J (JNJ) sign deals with U.S. government for coronavirus vaccine candidate. Several drugmakers announce second-quarter results.

The Zacks Analyst Blog Highlights: Apple, Mastercard, Eli Lilly, PetroChina and Anheuser-Busch InBev

From Zacks Investment Research Aug 7, 2020

The Zacks Analyst Blog Highlights: Apple, Mastercard, Eli Lilly, PetroChina and Anheuser-Busch InBev